Dalfampridine
NDC 62756-429, Dalfampridine, tablet, extended release, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 62756-429
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208292
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62756-429 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DALFAMPRIDINE10 mg/1
Pharmacologic classes
Potassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62756-429-86 | 62756042986 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (62756-429-86) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d61e15fa-0334-49a0-ab41-c9a36b726b57
Use it
Look up 62756-429 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62756-429 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62756-429. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.